| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 08.02.
| 1 Reason Boston Scientific Looks Attractive | | 2 | Motley Fool |
| 08.02.
| Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries | | 7 | PR Newswire |
| NATICK, Mass., Feb. 8, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the U.S. launch of the TruePath' CTO Device, designed to facilitate the crossing of...
Mehr lesen zu:
Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries | |
| 07.02.
| Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference | | 45 | PR Newswire |
| NATICK, Mass., Feb. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New York.
Hank...
Mehr lesen zu:
Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference | |
| 07.02.
| Boston Scientific (BSX)Get Trifecta of Positive Data from WallFlex Stent Studies | | 2 | StreetInsider.com |
| 07.02.
| Boston Scientific WallFlex® Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries | | 23 | PR Newswire |
| NATICK, Mass., Feb. 7, 2012 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) welcomes positive results from three studies of the WallFlex® Enteral Stent Systems, a family of self-expanding...
Mehr lesen zu:
Boston Scientific WallFlex® Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries | |
| 06.02.
| Boston Scientific Launches Expect19 Flex Endoscopic Ultrasound Aspiration Needle | | 38 | AFX News |
| WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced the global
introduction of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used
for acquiring tissue samples under...
Mehr lesen zu:
Boston Scientific Launches Expect19 Flex Endoscopic Ultrasound Aspiration Needle | |
| 06.02.
| Boston Scientific Announces Global Launch of Expect' 19 Flex Endoscopic Ultrasound Aspiration Needle | | 22 | PR Newswire |
| NATICK, Mass., Feb. 6, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used...
Mehr lesen zu:
Boston Scientific Announces Global Launch of Expect' 19 Flex Endoscopic Ultrasound Aspiration Needle | |
| 03.02.
| Boston Scientific Approaches New Upside Target of $6.07 | | 1 | SmarTrend |
| 03.02.
| The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | | 89 | PR Newswire |
| CHICAGO, Feb. 3, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | |
| 03.02.
| Conditions of Growth, Economic Analysis -- Research Report on Pfizer Inc. and Boston Scientific Corporation | | 30 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/03/12 -- Today, www.EquityLeader.com introduced research coverage of Pfizer Inc. (NYSE: PFE) and Boston Scientific Corporation (NYSE: BSX). Full research reports are...
Mehr lesen zu:
Conditions of Growth, Economic Analysis -- Research Report on Pfizer Inc. and Boston Scientific Corporation | |
| 03.02.
| Boston Scientific Announces CE Mark Approval and European Launch for New Infinion? 16 Percutaneous Lead for Precision Plus? Spinal Cord Stimulator System | | 59 | news aktuell |
| Paris and Miami Beach, Florida (ots/PRNewswire) - Boston Scientific Corporation announces CE Mark approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator...
Mehr lesen zu:
Boston Scientific Announces CE Mark Approval and European Launch for New Infinion? 16 Percutaneous Lead for Precision Plus? Spinal Cord Stimulator System | |
| 03.02.
| Boston Scientific Announces CE Mark Approval and European Launch for New Infinion' 16 Percutaneous Lead for Precision Plus' Spinal Cord Stimulator System | | 44 | PR Newswire |
| PARIS and MIAMI BEACH, Florida, February 3, 2012 /PRNewswire/ --
Boston Scientific Corporation (NYSE: BSX) announces CE Mark approval of the Infinion™ 16 Percutaneous Lead for its Precision Plus™...
Mehr lesen zu:
Boston Scientific Announces CE Mark Approval and European Launch for New Infinion' 16 Percutaneous Lead for Precision Plus' Spinal Cord Stimulator System | |
| 02.02.
| Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript | | - | Seeking Alpha |
| 02.02.
| Fool Cheat Sheet: Boston Scientific Earnings | | 3 | Motley Fool |
| 02.02.
| Thursday's Headliners: Sandridge Energy Inc., Nokia Inc., Pfizer Inc., Boston Scientific Corp., Las Vegas Sands Corp., Bank of America | | 95 | MarketWire |
| LAS VEGAS, NEVADA -- (Marketwire) -- 02/02/12 -- Rocket Alerts is a leading investment newsletter which supplies you with multi-track data on the hottest stocks in the market. Our Multi-Vector Stock...
Mehr lesen zu:
Thursday's Headliners: Sandridge Energy Inc., Nokia Inc., Pfizer Inc., Boston Scientific Corp., Las Vegas Sands Corp., Bank of America | |
| 02.02.
| Boston Scientific Bearish Moving Average Crossover Alert | | 1 | SmarTrend |
| 02.02.
| Boston Scientific markets Promus Element platinum stent in Europe | | - | Platinum today |
| 02.02.
| ROUNDUP: Boston Scientific Q4 Profit Declines; Guides 2012 Earnings Above View | | 34 | AFX News |
| WASHINGTON (dpa-AFX) - Medical devices maker Boston Scientific Corp. (BSX)
reported Thursday a decline in fourth-quarter profit, reflecting mainly lower
sales from its heart devices. Adjusted...
Mehr lesen zu:
ROUNDUP: Boston Scientific Q4 Profit Declines; Guides 2012 Earnings Above View | |
| 02.02.
| Boston Scientific: Struggles Today, Still Hope For Tomorrow? | | 4 | Seeking Alpha |
| 02.02.
| Boston Scientific Q4 Profit Declines; Guides Q1, 2012 | | 25 | AFX News |
| WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) reported fourth-quarter
profit of $107 million or $0.07 per share, lower than $236 million or $0.15 per
share a year ago.
The recent...
Mehr lesen zu:
Boston Scientific Q4 Profit Declines; Guides Q1, 2012 | |
